hydralazine has been researched along with Atrial Fibrillation in 10 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is a powerful risk factor of atrial fibrillation (AF)." | 1.42 | Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats. ( Chishaki, A; Hirooka, Y; Inoue, S; Kishi, T; Mukai, Y; Nagayama, T; Sunagawa, K; Takase, S; Takemoto, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagayama, T | 1 |
| Hirooka, Y | 1 |
| Kishi, T | 1 |
| Mukai, Y | 1 |
| Inoue, S | 1 |
| Takase, S | 1 |
| Takemoto, M | 1 |
| Chishaki, A | 1 |
| Sunagawa, K | 1 |
| Kopecky, SL | 1 |
| Litin, SC | 1 |
| Mitchell, JE | 1 |
| Tam, SW | 1 |
| Trivedi, K | 1 |
| Taylor, AL | 1 |
| O'Neal, W | 1 |
| Cohn, JN | 2 |
| Worcel, M | 1 |
| Alloway, JA | 1 |
| Salata, MP | 1 |
| Carson, PE | 1 |
| Johnson, GR | 1 |
| Dunkman, WB | 1 |
| Fletcher, RD | 1 |
| Farrell, L | 1 |
| Stevenson, WG | 1 |
| Stevenson, LW | 1 |
| Middlekauff, HR | 1 |
| Fonarow, GC | 1 |
| Hamilton, MA | 1 |
| Woo, MA | 1 |
| Saxon, LA | 1 |
| Natterson, PD | 1 |
| Steimle, A | 1 |
| Walden, JA | 1 |
| Tillisch, JH | 1 |
| Li, D | 1 |
| Shinagawa, K | 1 |
| Pang, L | 1 |
| Leung, TK | 1 |
| Cardin, S | 1 |
| Wang, Z | 1 |
| Nattel, S | 1 |
| Taguchi, J | 1 |
| Freis, ED | 1 |
| Belic, N | 1 |
| Talano, JV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00047775] | Phase 4 | 1,100 participants | Interventional | 2001-05-31 | Completed | ||
| Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)[NCT00156728] | Phase 4 | 172 participants | Interventional | 2003-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydralazine and Atrial Fibrillation
| Article | Year |
|---|---|
Quinidine-induced rheumatic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Atrial Fibrillation; Child; Diagnosis, Diff | 1995 |
4 trials available for hydralazine and Atrial Fibrillation
| Article | Year |
|---|---|
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
Topics: Atrial Fibrillation; Black or African American; Drug Combinations; Female; Follow-Up Studies; Heart | 2011 |
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Topics: Atrial Fibrillation; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isoso | 1993 |
Partial versus complete control of blood pressure in the prevention of hypertensive complications.
Topics: Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Follow-Up St | 1975 |
Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
Topics: Adult; Age Factors; Aged; Aneurysm; Atrial Fibrillation; Blood Glucose; Blood Pressure; Cerebrovascu | 1972 |
5 other studies available for hydralazine and Atrial Fibrillation
| Article | Year |
|---|---|
Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; A | 2015 |
Clinical pearls in cardiology.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiomyopathy, Dilated; Diuretics; Female; Heart Failure | 2010 |
Improving survival for patients with atrial fibrillation and advanced heart failure.
Topics: Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fi | 1996 |
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electr | 2001 |
Current concepts in sick sinus syndrome. II. ECG manifestation and diagnostic and therapeutic approaches.
Topics: Atrial Fibrillation; Atropine; Bradycardia; Cardiac Pacing, Artificial; Electric Stimulation; Electr | 1985 |